Frederik Denorme – The New PI at the Laboratory of Cell Biology and Histology at University of Antwerp
Frederik Denorme, Tenure Track Assistant Professor at University of Antwerp, shared on LinkedIn:
”After seven incredible years in the US, my family and I have made the decision to move back to Belgium.
Last week marked the beginning of my new role as a PI at the Laboratory of Cell Biology and Histology at University of Antwerp.
In this position, I will be merging my translational stroke research line with the group’s extensive expertise in Neurobiology, Imaging, and Infectious diseases.
Reflecting on this transition, I am filled with both excitement for the future and gratitude for my time in the US.
During my journey, I had the privilege to meet and collaborate with numerous brilliant scientists.
I am particularly thankful to my mentors Robert Campbell, Jennifer Juhl Majersik, Matthew Rondina, Paul Bray and Adeoye Opeolu, whose guidance was instrumental in shaping my research endeavors at University of Utah and later at Washington University in St. Louis.”
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis